Sanofi to work with Biovac to boost African vaccine capacity

French vaccines major Sanofi (Euronext: SAN) and Biovac, a Cape Town, South Africa-based biopharmaceutical company, have announced a partnership to produce inactivated polio vaccines in Africa.

Polio, a highly contagious disease affecting mainly children under five, can cause irreversible paralysis and death. Immunization is the only prevention method.

Despite significant progress, polio remains endemic in numerous countries around the world, including Afghanistan and Pakistan, highlighting the need for continued vaccination efforts globally.